Cargando…
Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients
The intent of this study was an evaluation of our effort to reduce the incidence of hypercalcemia in critically ill vitamin D-deficient patients with multiple traumatic injuries given cholecalciferol. Vitamin D deficiency was defined as a serum 25-hydroxy vitamin D concentration (25-OH vit D) of <...
Autores principales: | Dickerson, Roland N., Turner, Stephen C., Holmes, Whitney L., Van Matre, Edward T., Swanson, Joseph M., Byerly, Saskya, Filiberto, Dina M., Fischer, Peter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032836/ https://www.ncbi.nlm.nih.gov/pubmed/35458212 http://dx.doi.org/10.3390/nu14081650 |
Ejemplares similares
-
Falsely Elevated 25-Hydroxy-Vitamin D Levels in Patients with Hypercalcemia
por: Choi, Moon Kyung, et al.
Publicado: (2020) -
Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020) -
Vitamin D Status and Pregnancy Complications: Serum 1,25-di-hydroxyl-Vitamin D and its Ratio to 25-hydroxy-Vitamin D are Superior Biomarkers than 25-hydroxy-Vitamin D
por: Albahlol, Ibrahim A., et al.
Publicado: (2020) -
ODP079 BCG-Osis, a Rare Cause of 1,25 Hydroxy Vitamin D Mediated Hypercalcemia
por: Azim, Sidra, et al.
Publicado: (2022) -
The variation in free 25-hydroxy vitamin D and vitamin D-binding protein with season and vitamin D status
por: Oleröd, Göran, et al.
Publicado: (2017)